Daniele Tavernari

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Daniele Tavernari

Dec 25, 2024, 02:57 | Insight

Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), posted the following on X:…

Dec 22, 2024, 13:45 | Science

Details on uncommon EGFR mutations in NSCLC from Dr. Alfredo Addeo

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…

Dec 22, 2024, 10:44 | Science

5 papers about Lung Cancer suggested by Stephen Liu

Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…

Dec 18, 2024, 15:38 | Blog

Incidence and outcomes of molecular subtypes of EGFR+ NSCLC

Jarushka Naidoo shared on X: "Important paper on incidence and outcomes of molec subtypes of…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023